Reprogenetics: Research Validates Preimplantation Genetic Diagnosis for Aneuploidy (PGD-A) as a Valuable Tool in Identifying Viable Embryos During In Vitro Fertilization (IVF)

Fertility and Sterility Published Research Yields Insight on Detection of Mosaicism Aiding in Embryo Selection, Resulting in Higher Implantation Rates and Lower Rates of MiscarriageLIVINGSTON, NJ-(Marketwired - Apr 12, 2016) - Reprogenetics, the largest genetics laboratory in the United States specializing in Preimplantation Genetic Diagnosis (PGD), has published a clinical paper on the use ofThe post Research Validates Preimplantation Genetic Diagnosis for Aneuploidy (PGD-A) as a Valuable Tool in Identifying Viable Embryos During In Vitro Fertilization (IVF) appeared first on Investing News Network.